Finlanda: Antithrombotic agents, blood substitutes and perfusion solutions, and antihemorrhagics
Data licitatiei 05.12.2024
au mai rămas 30 zile
3
3
Valoare estimata : 0
|
Tip anunt:
UE
|
ID: 8934657
|
Data publicarii :
05.11.2024
|
Tara/Judet:
FI |
Descriere scurta:
Finlanda: Antithrombotic agents, blood substitutes and perfusion solutions, and antihemorrhagics
Coduri CPV:
33600000-6 - Produse farmaceutice
33621000-9 - Medicamente pentru sânge şi pentru organele hematopoietice
33621100-0 - Antitrombotice
33621200-1 - Antihemoragice
33621400-3 - Substituenţi de plasmă sanguină şi soluţii pentru perfuzii
|
Textul licitației
t. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in five (5) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Enoxaparin sodium 100 mg/ml (1 ml sub cutan, vial/ampoule/prefilled syringe, ATC B01AB05) LOT 2: 5 % glucose electrolyte solution (1000 ml, i.v., infusion bag, 5 % solution, ATC B05BB02) LOT 3: Calcium gluconate 100 mg/ml (10 ml i.v., vial/ampoule, ATC B05BB01) LOT 4: Freeze-dried plasma, powder and solvent for infusion (200 ml, bottle, ATC B05AA) LOT 5: Tranexamic acid 100 mg/ml (10 ml, i.v., vial/ampoule, ATC B02AA02) The minimum requirements for the products is described in Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the p